Year : 2017 | Volume
: 36 | Issue : 4 | Page : 352--359
Portal and mesenteric vein resection during pancreaticoduodenectomy and total pancreatectomy
Hazem M Zakaria1, John A Stauffer2, Eijiro Harada3, Horacio J Asbun2
1 Department of Hepatopancreatobiliary and Liver Transplantation Surgery, National Liver Institute, Menoufia University, Menoufia, Egypt
2 Department of Surgery, Mayo Clinic, Jacksonville, Florida, USA
3 Department of Organ Regulatory Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
Portal vein invasion by a malignant pancreatic mass is currently not a contraindication to pancreatic resection with acceptable oncologic outcomes.
The aim of this paper was to identify the perioperative morbidity and long-term outcomes of venous resection (VR) during pancreaticoduodenectomy (PD) and total pancreatectomy (TP) operations.
Materials and methods
We carried out a retrospective study of patients undergoing PD or TP between March 1995 and December 2014 at Mayo Clinic in Jacksonville, Florida, using data collected from an institutional review board-approved prospective database. Preoperative, operative, and postoperative clinicopathological data were collected and analyzed.
Out of 601 patients who underwent PD and TP in this study, 104 (17.3%) underwent VR. The types of VR and reconstruction were as follows: type I (lateral venorrhaphy) in 49 (47.1%) patients, type II (patch graft) in 10 (9.6%) patients, type III (primary anastomosis) in 27 (26%) patients, and type IV (interposition venous graft) in 16 (15.4%) patients. Two (1.9%) patients underwent no portomesenteric reconstruction. The 90-day major postoperative complications and mortality in patients with VR were 44.2 and 7.7%, respectively, versus 29.2 and 4.4%, respectively, in patients with standard resection. The 1-year, 3-year, 5-year, and 7-year survival rates in VR with periampullary adenocarcinoma (PAAC) were 55.1, 27, 21.9, and 15.4%, respectively, whereas in patients with PAAC without VR, the survival rates were 78.4, 45.6, 34.6, and 30.9%, respectively (P<0.01).
VR and reconstruction with PD can be performed safely with acceptable perioperative morbidity and long-term survival rates to achieve complete removal of the tumor.
John A Stauffer
Division of General Surgery, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224
|How to cite this article:|
Zakaria HM, Stauffer JA, Harada E, Asbun HJ. Portal and mesenteric vein resection during pancreaticoduodenectomy and total pancreatectomy.Egypt J Surg 2017;36:352-359
|How to cite this URL:|
Zakaria HM, Stauffer JA, Harada E, Asbun HJ. Portal and mesenteric vein resection during pancreaticoduodenectomy and total pancreatectomy. Egypt J Surg [serial online] 2017 [cited 2018 Aug 21 ];36:352-359
Available from: http://www.ejs.eg.net/article.asp?issn=1110-1121;year=2017;volume=36;issue=4;spage=352;epage=359;aulast=Zakaria;type=0